dapsone has been researched along with methotrexate in 56 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (8.93) | 18.7374 |
| 1990's | 8 (14.29) | 18.2507 |
| 2000's | 13 (23.21) | 29.6817 |
| 2010's | 29 (51.79) | 24.3611 |
| 2020's | 1 (1.79) | 2.80 |
| Authors | Studies |
|---|---|
| Genther, CS; Smith, CS | 1 |
| Queener, SF | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bera, S; Mondal, D | 1 |
| Callen, JP; Gruber, GG | 1 |
| Friedman-Birnbaum, R; Haim, S | 1 |
| Norris, DA; Sams, WM; Weston, WL | 1 |
| Bellamy, N; Dewar, CL | 1 |
| Moore, SE; Smiley, JD | 1 |
| Conn, DL; Valente, RM | 1 |
| Moss, RB | 1 |
| Nesher, G; Sonnenblick, M | 1 |
| Jorizzo, JL; Mangelsdorf, HC; White, WL | 1 |
| Coleman, MD; Gardiner, JM; Pahal, KK | 1 |
| Spector, SL | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Ahmed, AR; Baltatzis, S; Foster, CS; Miserocchi, E; Roque, MR | 1 |
| Charte González, A; Folch Civit, J; Robert Olalla, J; Rufi Rigau, G; Sanuy Jiménez, B; Vidaller Palacín, A | 1 |
| Bygum, A; Clemmensen, O; Gniadecki, R; Svejgaard, E; Ullman, S | 1 |
| Ahmed, RA; Sami, N; Yeh, SW | 1 |
| Bieber, T; Tüting, T; Uerlich, M; Wenzel, J | 1 |
| Aydog, E; Sever, A; Usan, H; Yesilli, O | 1 |
| Liozon, E; Ly, K | 1 |
| Lehman, JS; Mueller, KK; Schraith, DF | 1 |
| Cho, KH; Choi, JW; Kim, BK; Park, HS | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Billings, SD; Hoschar, AP; McDonnell, JK; Rushing, EC | 1 |
| Bessis, D; Gil-Bistes, D; Guillot, B; Kluger, N | 1 |
| Chang, AY; Werth, VP | 1 |
| Devoto, MH; Fernández Romero, DS; Georgiett, D; Juri, MC; Malbrán, A; Zárate, JO | 1 |
| Callen, JP; Femia, AN; Vleugels, RA | 1 |
| Loke, YK; MacGregor, AJ; Watts, RA; Yates, M | 1 |
| Delaplace, M; Estève, E; Raffin, D; Roussel, A | 1 |
| Al-Ismail, D; Anderson, E; Batul Syed, S; Burden-Teh, E; Carmichael, A; Caruana, D; Darne, S; Dolman, S; Glover, M; Helbling, I; Hughes, B; Hughes, J; Jones, V; Jury, C; Kalavala, M; Katugampola, R; Lam, ML; McPherson, T; Moore, A; Murphy, R; Natarajan, S; Richards, L; Taibjee, SM; Taylor, A; Webster, S | 1 |
| Garza-Mayers, AC; McClurkin, M; Smith, GP | 1 |
| Aberer, E; Bata-Csörgő, Z; Caproni, M; Dreher, A; Frances, C; Gläser, R; Klötgen, HW; Kuhn, A; Landmann, A; Marinovic, B; Nyberg, F; Olteanu, R; Ranki, A; Szepietowski, JC; Volc-Platzer, B | 1 |
| Carter, JD; Patel, AA; Raturi, R | 1 |
| Nutan, F; Ortega-Loayza, AG | 1 |
| Bajaj, S; Bose, SK; Sardana, K | 1 |
| Al Nahlawi, B; Hayat, SQ; Katikaneni, M; Nambiar, PH | 1 |
| Gieler, U; Husein-ElAhmed, H; Steinhoff, M | 1 |
| Malhotra, R; Sehgal, VN | 1 |
| Bielach-Bazyluk, A; Flisiak, I; Pilaszewicz-Puza, A; Serwin, AB | 1 |
22 review(s) available for dapsone and methotrexate
| Article | Year |
|---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship | 1995 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Systemic complications of commonly used dermatologic drugs.
Topics: Blood; Cataract; Dapsone; Dermatitis; Glaucoma; Glucocorticoids; Growth; Humans; Kidney; Liver; Methotrexate; Peptic Ulcer; Skin Diseases; Tetracycline | 1978 |
Immune-complex vasculitis: role of complement and IgG-Fc receptor functions.
Topics: Cyclophosphamide; Dapsone; Humans; Immune Complex Diseases; Immunoglobulin G; Methotrexate; Receptors, Complement; Vasculitis | 1989 |
Current therapies for systemic vasculitis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunization, Passive; Methotrexate; Plasmapheresis; Vasculitis | 1994 |
Alternative pharmacotherapies for steroid-dependent asthma.
Topics: Adrenal Cortex Hormones; Asthma; Clinical Trials as Topic; Cyclosporine; Dapsone; Furosemide; Gold; Humans; Hydroxychloroquine; Magnesium Sulfate; Methotrexate; Treatment Outcome; Troleandomycin | 1995 |
Steroid-sparing medications in temporal arteritis--report of three cases and review of 174 reported patients.
Topics: Aged; Aged, 80 and over; Dapsone; Female; Giant Cell Arteritis; Humans; Methotrexate; Prednisone | 1994 |
Alternative treatments in the patient with intractable asthma.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Infective Agents; Antirheumatic Agents; Asthma; Cyclosporine; Dapsone; Humans; Hydroxychloroquine; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Organogold Compounds; SRS-A; Troleandomycin | 1997 |
[Behcet's disease therapy review].
Topics: Behcet Syndrome; Colchicine; Dapsone; Humans; Methotrexate; Prednisone; Thalidomide | 2002 |
Treatment of pemphigus vulgaris: current and emerging options.
Topics: Administration, Oral; Adrenal Cortex Hormones; Combined Modality Therapy; Dapsone; Dexamethasone; Female; Follow-Up Studies; Humans; Immunotherapy; Male; Methotrexate; Mycophenolic Acid; Pemphigus; Photochemotherapy; Plasmapheresis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2005 |
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimalarials; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dapsone; Dermatologic Agents; Female; Gold; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Cutaneous; Male; Methotrexate; Plasmapheresis; Pregnancy; Retinoids; Thalidomide; Time Factors | 2003 |
[Giant cell arteritis].
Topics: Adrenal Cortex Hormones; Aged, 80 and over; Anti-Infective Agents; Biopsy; Blood Sedimentation; C-Reactive Protein; Dapsone; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Positron-Emission Tomography; Prognosis; Radiography; Recurrence; Temporal Arteries; Time Factors; Ultrasonography, Doppler, Duplex | 2008 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Treatment of cutaneous lupus.
Topics: Administration, Topical; Antimalarials; Calcineurin Inhibitors; Dapsone; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Sunscreening Agents; Thalidomide | 2011 |
Cutaneous dermatomyositis: an updated review of treatment options and internal associations.
Topics: Antibodies, Monoclonal, Murine-Derived; Dapsone; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Mycophenolic Acid; Prognosis; Risk Assessment; Rituximab; Stem Cell Transplantation; Treatment Outcome | 2013 |
Prednisolone combined with adjunctive immunosuppression is not superior to prednisolone alone in terms of efficacy and safety in giant cell arteritis: meta-analysis.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dapsone; Female; Giant Cell Arteritis; Humans; Hydroxychloroquine; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Prednisolone; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Treatment Outcome; Vasculitis | 2014 |
Review of treatment for discoid lupus erythematosus.
Topics: Adrenal Cortex Hormones; Calcineurin Inhibitors; Dapsone; Humans; Hydroxychloroquine; Laser Therapy; Lupus Erythematosus, Discoid; Methotrexate; Phototherapy; Retinoids; Smoking Cessation; Thalidomide | 2016 |
Two cases demonstrating thalidomide's efficacy in refractory lupus nephritis.
Topics: Adolescent; Adult; Dapsone; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methotrexate; Mycophenolic Acid; Thalidomide; Treatment Outcome | 2017 |
Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antimalarials; Calcineurin Inhibitors; Dapsone; Humans; Immunologic Factors; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Thalidomide | 2017 |
Lichen planus: a comprehensive evidence-based analysis of medical treatment.
Topics: Administration, Oral; Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Calcineurin Inhibitors; Calcitriol; Cyclosporine; Dapsone; Dermatologic Agents; Enoxaparin; Evidence-Based Medicine; Humans; Hydroxychloroquine; Lichen Planus; Methotrexate; Mycophenolic Acid; Retinoids; Tacrolimus; Ultraviolet Therapy | 2019 |
Cutaneous Rosai - Dorfman disease in a patient with late syphilis and cervical cancer - case report and a review of literature.
Topics: Biopsy; Chemoradiotherapy, Adjuvant; Dapsone; Doxycycline; Drug Therapy, Combination; Female; Histiocytosis, Sinus; Humans; Hysterectomy; Methotrexate; Middle Aged; Skin; Syphilis; Uterine Cervical Neoplasms | 2020 |
34 other study(ies) available for dapsone and methotrexate
| Article | Year |
|---|---|
Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli.
Topics: Animals; Antimalarials; Bacteria; Drug Resistance, Microbial; Escherichia coli; Folic Acid; Folic Acid Antagonists; Malaria; Mice; Plasmodium berghei; Triazines | 1977 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Dapsone in the treatment of pemphigus vulgaris.
Topics: Adult; Dapsone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Pemphigus; Prednisone; Recurrence | 1978 |
The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro.
Topics: Anti-Inflammatory Agents; Blood Bactericidal Activity; Chemotaxis; Chloroquine; Cyclophosphamide; Dapsone; Dexamethasone; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Monocytes; Phagocytosis; Sulfapyridine; Vinblastine | 1977 |
Necrotizing mesenteric vasculitis after longstanding cutaneous polyarteritis nodosa.
Topics: Adult; Azathioprine; Cyclophosphamide; Dapsone; Female; Humans; Mesenteric Arteries; Methotrexate; Necrosis; Plasmapheresis; Polyarteritis Nodosa; Potassium Iodide; Prednisone; Vasculitis | 1992 |
Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Colchicine; Dapsone; Dermatologic Agents; Female; Genital Diseases, Female; Genital Diseases, Male; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intralesional; Male; Methotrexate; Middle Aged; Neutrophils; Retrospective Studies; Skin Ulcer; Stomatitis, Aphthous; Thalidomide; United States; Vasculitis, Leukocytoclastic, Cutaneous | 1996 |
The effect of acetylation and deacetylation on the disposition of dapsone and monoacetyl dapsone hydroxylamines in human erythrocytes in-vitro.
Topics: Acedapsone; Acetylation; Adult; Amines; Anti-Infective Agents; Chromatography, High Pressure Liquid; Dapsone; Dealkylation; Erythrocytes; Folic Acid; Folic Acid Antagonists; Glucose; Hematinics; Humans; In Vitro Techniques; Methemoglobin; Methotrexate | 1996 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathioprine; Conjunctivitis; Cyclophosphamide; Dapsone; Disease Progression; Drug Hypersensitivity; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigoid, Benign Mucous Membrane; Prednisone; Visual Acuity | 2002 |
IgA pemphigus: the first two Scandinavian cases.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Blister; Dapsone; Dermatologic Agents; Diagnosis, Differential; Drug Therapy, Combination; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin A; Male; Methotrexate; Microscopy, Confocal; Middle Aged; Pemphigus; Prednisolone; Scandinavian and Nordic Countries; Skin; Treatment Outcome | 2002 |
Dermatitis herpetiformis and rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Dapsone; Dermatitis Herpetiformis; Epidermis; Humans; Hydroxychloroquine; Male; Methotrexate; Methylprednisolone; Middle Aged | 2006 |
Do safe and effective treatment options exist for patients with active pemphigus vulgaris who plan conception and pregnancy?
Topics: Administration, Oral; Adult; Anti-Infective Agents; Dapsone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Family Planning Services; Female; Fertilization; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Pemphigus; Prednisone; Pregnancy; Pregnancy Complications; Prognosis; Risk Factors | 2008 |
Lupus erythematosus panniculitis: clinicopathological, immunophenotypic, and molecular studies.
Topics: Adolescent; Adult; Aged; B-Lymphocytes; Biomarkers; Child; Dapsone; Drug Therapy, Combination; Fat Necrosis; Female; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Hydroxychloroquine; Immunoenzyme Techniques; Immunophenotyping; Male; Methotrexate; Middle Aged; Panniculitis, Lupus Erythematosus; Prednisolone; Retrospective Studies; Skin; T-Lymphocytes; Young Adult | 2010 |
Iatrogenic oral hairy leukoplakia: report of two cases.
Topics: Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Antifungal Agents; Arthritis, Rheumatoid; Clobetasol; Dapsone; Dermatologic Agents; Dexamethasone; Diabetes Mellitus, Type 2; Epstein-Barr Virus Infections; Female; Fluconazole; Humans; Immunocompromised Host; Leukoplakia, Hairy; Lichen Planus; Methotrexate; Nystatin; Prednisone; Zinc Oxide | 2011 |
Efficacy of anti-interleukin-1 receptor antagonist anakinra (Kineret®) in a case of refractory Sweet's syndrome.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Colchicine; Dapsone; Dermatologic Agents; Humans; Interleukin 1 Receptor Antagonist Protein; Male; Methotrexate; Neutrophils; Prednisone; Receptors, Interleukin-1; Rituximab; Sweet Syndrome; Treatment Outcome | 2011 |
[Systemic treatment of ocular cicatricial pemphigoid].
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Dapsone; Delayed Diagnosis; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigoid, Benign Mucous Membrane; Severity of Illness Index; Treatment Outcome | 2012 |
[Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept®)].
Topics: Aged; Autoantibodies; Autoantigens; Clobetasol; Dapsone; Drug Resistance; Humans; Immunoglobulin G; Immunosuppressive Agents; Laminin; Male; Methotrexate; Mycophenolic Acid; Pemphigoid, Benign Mucous Membrane; Pemphigoid, Bullous; Prednisolone; Remission Induction; Skin | 2013 |
How are we using systemic drugs to treat psoriasis in children? An insight into current clinical U.K. practice.
Topics: Acitretin; Adolescent; Child; Child, Preschool; Cyclosporine; Dapsone; Dermatologic Agents; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Practice Patterns, Physicians'; Psoriasis; United Kingdom | 2015 |
S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).
Topics: Adrenal Cortex Hormones; Antimalarials; Biological Products; Calcineurin Inhibitors; Consensus; Dapsone; Humans; Immunosuppressive Agents; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Practice Guidelines as Topic; Retinoids; Thalidomide | 2017 |
Successful treatment of PAPA syndrome with minocycline, dapsone, deflazacort and methotrexate: a cost-effective therapy with a 2-year follow-up.
Topics: Acne Vulgaris; Anti-Inflammatory Agents; Arthritis, Infectious; Cost-Benefit Analysis; Dapsone; Dermatologic Agents; Drug Therapy, Combination; Humans; Methotrexate; Minocycline; Pregnenediones; Pyoderma Gangrenosum; Skin | 2019 |
Leprosy after interleukin 6 inhibitor therapy in a patient with rheumatoid arthritis.
Topics: Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Dapsone; Exanthema; Female; Humans; Leprostatic Agents; Leprosy, Tuberculoid; Methotrexate; Middle Aged; Prednisone; United States | 2019 |
Pharmacology and Therapeutics of Corticosteroids Sparing Maintenance Immunosuppressive/Adjunct Therapy Drugs.
Topics: Anti-Infective Agents; Azathioprine; Cyclophosphamide; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferons; Methotrexate; Skin Diseases | 2019 |